Implantable nerve stimulation for obstructive sleep apnea hypopnea syndrome | Traitement du syndrome d’apnées et hypopnées obstructives du sommeil par stimulation nerveuse implantable
La Presse Médicale. 2016-02-01; 45(2): 183-192
DOI: 10.1016/j.lpm.2015.11.008
Lire sur PubMed
1. Presse Med. 2016 Feb;45(2):183-92. doi: 10.1016/j.lpm.2015.11.008. Epub 2016 Jan
13.
[Implantable nerve stimulation for obstructive sleep apnea hypopnea syndrome].
[Article in French]
Afonso Delgado L(1), Micoulaud Franchi JA(2), Monteyrol PJ(3), Philip P(4).
Author information:
(1)CHU de Bordeaux, pôle de neurosciences cliniques (PNC), place
Amélie-Raba-Léon, 33076 Bordeaux, France.
(2)CHU de Bordeaux, clinique du sommeil, service d’explorations fonctionnelles du
système nerveux, place Amélie-Raba-Léon, 33076 Bordeaux, France; USR CNRS 3413
SANPSY, CHU Pellegrin, université de Bordeaux, Bordeaux, France. Electronic
address: .
(3)CHU de Bordeaux, clinique du sommeil, service d’explorations fonctionnelles du
système nerveux, place Amélie-Raba-Léon, 33076 Bordeaux, France.
(4)CHU de Bordeaux, clinique du sommeil, service d’explorations fonctionnelles du
système nerveux, place Amélie-Raba-Léon, 33076 Bordeaux, France; USR CNRS 3413
SANPSY, CHU Pellegrin, université de Bordeaux, Bordeaux, France.
Obstructive sleep apnea hypopnea syndrome (OSAHS) is a common disorder that has
been identified as a contributor to cardiovascular disease making it a major
public health problem. Continuous positive airway pressure is the standard
treatment but compliance is suboptimal. Mandibular advancement devices and
surgery have limited indications, inconstant efficiency and potential
irreversible side effects. Stimulation of the hypoglossal nerve, that innervates
the genioglossus, a protrusor muscle of the tongue, is now a new treatment option
for moderate and severe cases of OSAHS. Two types of stimulation are currently
available: stimulation synchronous with inspiration and continuous stimulation.
The indication of each type of stimulation and long-term effects still need to be
assessed but the implantable nerve stimulation is a promising treatment for
patients without a therapy solution so far.
Copyright © 2015 Elsevier Masson SAS. All rights reserved.
DOI: 10.1016/j.lpm.2015.11.008
PMID: 26796478 [Indexed for MEDLINE]